Análisis Argos
GH
GHSin veredicto2 señales de riesgo
Guardant Health, Inc. · Healthcare
US$ 143.62
precio al 2026-07-28
Valor justo Argos*
Sin estimar
vs. su valor justo
Sin estimar
Score Argos
24/100
Sin veredicto
LA RESPUESTA
No tenemos un veredicto de valuación confiable acá: su flujo de caja no permite una estimación sólida. Mirá su calidad y su salud para formarte una idea — preferimos eso a inventarte un número.
Recompensas
Sin recompensas destacadas.
Riesgos
!Balance frágil: la deuda pesa sobre el negocio.
!Altman Z'' en zona roja (-2.56)
!FCF negativo con deuda creciente
VALOR1/6FUTURO6/6PASADO2/6SALUD1/6DIVIDENDO0/6
El Iris de calidad
VALOR1/6FUTURO6/6PASADO2/6SALUD1/6DIVIDENDO0/6
ValorCotiza por encima de su valor justo
FuturoIngresos creciendo con fuerza
PasadoHistorial aceptable
SaludBalance frágil
DividendoEl dividendo aún duerme
Score Argos24de 100Sin veredicto
Ingresos32%
US$ 1 B
Margen operativo26%
-44.4%
Flujo de caja libre15%
US$ -0.2 B
Deuda neta
US$ 1.3 B
Lo esencial, sin ruido
Cap. de mercadoUS$ 19.0B
P/E
EV/EBITDA
FCF yield-1.2%
ROIC-35.3%
Margen operativo-44.4%
Crecim. ingresos+32.9%/año
Piotroski F5/9
Competidores

Los rivales, con el mismo ojo

El Iris de calidad de cada competidor, lado a lado. Tocá uno para ver su análisis.

Novedades

Noticias recientes

businesswire.com · 9 jul
Guardant Health to Report Second Quarter 2026 Financial Results on July 30, 2026
PALO ALTO, Calif.--(BUSINESS WIRE)--Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced it will report financial results for the second quarter 2026 after market close on Thursday, July 30, 2026. Company management will webcast a corresponding conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time. Live audio of the webcast will be available on the “Investors” section of the company website at: www.guardanthealth.com. The webcast will.
investors.com · 9 jul
The Surprising Reason Guardant Health, A Top 3% Stock, Soared To A Five-Year High
Guardant Health stock jumped Thursday after key competitor, Freenome, unveiled study results for its colon cancer blood test.
fool.com · 7 jul
Which Small Cap ETF Is the Better Buy in 2026? iShares and JPMorgan Have Compelling Offerings
ISCB offers ultra-low costs and 1,500+ holdings for diversification, while BBSC concentrates on fewer names with higher recent returns.
businesswire.com · 1 jul
UnitedHealth Group Now Covers Guardant Health's Shield Blood Test for Colorectal Cancer Screening
PALO ALTO, Calif.--(BUSINESS WIRE)--Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced its Shield™ blood test for colorectal cancer screening (CRC) is now covered for eligible UnitedHealth Group (UHG) members1, making it the first major commercial insurer to provide coverage for adults 45 or older amid rising CRC rates for adults under 652 and mortality for younger adults as the leading cause of cancer death for those under 50.3 Shield is the first and onl.
fool.com · 30 jun
State Street SPDR Small Cap ETF Outpaces iShares on Returns
Explore how portfolio size and sector exposure differ between these two small-cap ETFs, each offering unique advantages for investors.
barrons.com · 18 jun
Living Longer Is Big Business. These Stocks Will Benefit.
TD Cowen analysts estimate that the total addressable market for longevity healthcare exceeds $250 billion.
newsfilecorp.com · 15 jun
Gamehost Receives Final Court Order Authorizing Sale to Pure Casino Entertainment
Not intended for distribution to U.S. newswire services or for dissemination in the U.S. Red Deer, Alberta--(Newsfile Corp. - June 15, 2026) - Gamehost Inc. (TSX: GH) ("Gamehost") announced that the Court of King's Bench of Alberta has granted the final order authorizing Gamehost to proceed with its previously announced transaction with Pure Casino Entertainment Limited Partnership ("Pure") pursuant to which a subsidiary of Pure will acquire all of the outstanding common shares of Gamehost (the "Gamehost Shares") for $13.65 in cash per share (the "Transaction"). The Transaction was approved at a special meeting of the shareholders of Gamehost (the "Gamehost Shareholders") held on June 11, 2026.
newsfilecorp.com · 12 jun
Gamehost Shareholders Approve Sale to Pure Casino Entertainment
Red Deer, Alberta--(Newsfile Corp. - June 12, 2026) - Gamehost Inc. (TSX: GH) ("Gamehost") announced that its shareholders (the "Gamehost Shareholders") have approved its previously announced transaction with Pure Casino Entertainment Limited Partnership ("Pure") pursuant to which a subsidiary of Pure will acquire all of the outstanding common shares of Gamehost (the "Gamehost Shares") for $13.65 in cash per share (the "Transaction"). The Transaction was approved at a special meeting of the Gamehost Shareholders held on June 11, 2026 (the "Meeting").

* Valor justo Argos: estimación educativa del valor intrínseco según el propio flujo de caja de la empresa y su capacidad de crecimiento — no un precio objetivo ni una recomendación. Esto es información y educación, no asesoría de inversión. Rendimiento pasado no garantiza resultados futuros.